Literature DB >> 21909780

[Allergic contact dermatitis and atopy].

M Niebuhr1, A Kapp, T Werfel, A Heratizadeh.   

Abstract

Retrospective studies demonstrate that the prevalence of skin sensitization does not significantly differ between atopic and non-atopic patients. In children and adolescents the risk for sensitization seems to occur independently from AD. According to the results of a recent study, AD patients are overrepresented in the group of polysensitized patients. IgE-mediated sensitization as well as an early onset of AD and duration of the disease have been identified as possible risk factors for skin sensitization to contact allergens. A defective permeability barrier with increased epidermal water loss is a hallmark of AD and contributes to sensitization against common allergens. A highly significant association between FLG mutations and the risk of early onset, severe, persistent AD and an increased risk for asthma has been shown in several studies. A more recent study revealed an association between FLG mutations and increased nickel sensitization, but not other contact allergens. However, further large prospective studies with well-characterized patients are necessary to clarify the correlation between impaired skin barrier, atopic dermatitis and allergic contact dermatitis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21909780     DOI: 10.1007/s00105-011-2182-1

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  39 in total

Review 1.  Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report.

Authors:  Cezmi A Akdis; Mübeccel Akdis; Thomas Bieber; Carsten Bindslev-Jensen; Mark Boguniewicz; Philippe Eigenmann; Qutayba Hamid; Alexander Kapp; Donald Y M Leung; Jasna Lipozencic; Thomas A Luger; Antonella Muraro; Natalija Novak; Thomas A E Platts-Mills; Lanny Rosenwasser; Annika Scheynius; F Estelle R Simons; Jonathan Spergel; Kristiina Turjanmaa; Ulrich Wahn; Stefan Weidinger; Thomas Werfel; Torsten Zuberbier
Journal:  J Allergy Clin Immunol       Date:  2006-07       Impact factor: 10.793

2.  Type-IV sensitization profile of individuals with atopic eczema: results from the Information Network of Departments of Dermatology (IVDK) and the German Contact Dermatitis Research Group (DKG).

Authors:  G Heine; A Schnuch; W Uter; M Worm
Journal:  Allergy       Date:  2006-05       Impact factor: 13.146

3.  Contact sensitization in atopic dermatitis: results of a prospective study of 89 cases in Tunisia.

Authors:  H Belhadjali; M Mohamed; M Youssef; S Mandhouj; M Chakroun; J Zili
Journal:  Contact Dermatitis       Date:  2008-03       Impact factor: 6.600

4.  [Atopic dermatitis: S2 guidelines].

Authors:  Thomas Werfel; Werner Aberer; Matthias Augustin; Tilo Biedermann; Regina Fölster-Holst; Frank Friedrichs; Uwe Gieler; Annice Heratizadeh; Alexander Kapp; Bernhard Przybilla; Ernst Rietschel; Martin Schlaeger; Peter Schmid-Grendelmeier; Helmut Sitters; Doris Staab; Rüdiger Szczepanski; Dieter Vieluf; Ingrid Voigtmann; Margitta Worm
Journal:  J Dtsch Dermatol Ges       Date:  2009-01       Impact factor: 5.584

5.  Contact allergy and allergic contact dermatitis in adolescents: prevalence measures and associations. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis (TOACS).

Authors:  Charlotte Gotthard Mortz; Jens Martin Lauritsen; Carsten Bindslev-Jensen; Klaus Ejner Andersen
Journal:  Acta Derm Venereol       Date:  2002       Impact factor: 4.437

6.  Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis.

Authors:  Mark M Neis; Bettina Peters; Alexandra Dreuw; Joerg Wenzel; Thomas Bieber; Cornelia Mauch; Thomas Krieg; Sven Stanzel; Peter C Heinrich; Hans F Merk; Andreas Bosio; Jens M Baron; Heike M Hermanns
Journal:  J Allergy Clin Immunol       Date:  2006-09-01       Impact factor: 10.793

7.  Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes.

Authors:  C Albanesi; C Scarponi; A Cavani; M Federici; F Nasorri; G Girolomoni
Journal:  J Invest Dermatol       Date:  2000-07       Impact factor: 8.551

8.  Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children.

Authors:  C Mailhol; V Lauwers-Cances; F Rancé; C Paul; F Giordano-Labadie
Journal:  Allergy       Date:  2009-01-31       Impact factor: 13.146

Review 9.  Patch tests in children with suspected allergic contact dermatitis: a prospective study and review of the literature.

Authors:  Flora B de Waard-van der Spek; Arnold P Oranje
Journal:  Dermatology       Date:  2008-10-22       Impact factor: 5.366

10.  Sensitizing potential of triclosan and triclosan-based skin care products in patients with chronic eczema.

Authors:  Donatella Schena; Anastasia Papagrigoraki; Giampiero Girolomoni
Journal:  Dermatol Ther       Date:  2008-10       Impact factor: 2.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.